메뉴 건너뛰기




Volumn 95, Issue 27, 2016, Pages

Urinary N -acetyl-β- d -glucosaminidase, an early marker of diabetic kidney disease, might reflect glucose excursion in patients with type 2 diabetes

Author keywords

glycated albumin; N acetyl d glucosaminidase; type 2 diabetes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; C PEPTIDE; CREATININE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; INSULIN; METFORMIN; N ACETYL BETA GLUCOSAMINIDASE; ORAL ANTIDIABETIC AGENT; SULFONYLUREA; ACETYLGLUCOSAMINIDASE; BIOLOGICAL MARKER;

EID: 84978764134     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000004114     Document Type: Article
Times cited : (43)

References (40)
  • 1
    • 84908219541 scopus 로고    scopus 로고
    • Diabetic kidney disease: A report from an ADA Consensus Conference
    • Tuttle KR, Bakris GL, Bilous RW, et al. Diabetic kidney disease: a report from an ADA Consensus Conference. Diabetes Care 2014;37: 2864-83
    • (2014) Diabetes Care , vol.37 , pp. 2864-2883
    • Tuttle, K.R.1    Bakris, G.L.2    Bilous, R.W.3
  • 2
    • 11844291920 scopus 로고    scopus 로고
    • Diabetic nephropathy: Diagnosis, prevention, and treatment
    • Gross JL, de Azevedo MJ, Silveiro SP, et al. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 2005;28:164-76
    • (2005) Diabetes Care , vol.28 , pp. 164-176
    • Gross, J.L.1    De Azevedo, M.J.2    Silveiro, S.P.3
  • 3
    • 70349235678 scopus 로고    scopus 로고
    • Integrating albuminuria and GFR in the assessment of diabetic nephropathy
    • Jerums G, Panagiotopoulos S, Premaratne E, et al. Integrating albuminuria and GFR in the assessment of diabetic nephropathy. Nat Rev Nephrol 2009;5:397-406
    • (2009) Nat Rev Nephrol , vol.5 , pp. 397-406
    • Jerums, G.1    Panagiotopoulos, S.2    Premaratne, E.3
  • 6
    • 84858323968 scopus 로고    scopus 로고
    • Urinary tubular biomarkers in shortterm type 2 diabetes mellitus patients: A cross-sectional study
    • Fu WJ, Xiong SL, Fang YG, et al. Urinary tubular biomarkers in shortterm type 2 diabetes mellitus patients: a cross-sectional study. Endocrine 2012;41:82-8
    • (2012) Endocrine , vol.41 , pp. 82-88
    • Fu, W.J.1    Xiong, S.L.2    Fang, Y.G.3
  • 7
    • 79551663082 scopus 로고    scopus 로고
    • Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes
    • Jeon YK, Kim MR, Huh JE, et al. Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes. J Korean Med Sci 2011;26:258-63
    • (2011) J Korean Med Sci , vol.26 , pp. 258-263
    • Jeon, Y.K.1    Kim, M.R.2    Huh, J.E.3
  • 8
    • 84865065019 scopus 로고    scopus 로고
    • Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients
    • Kim SS, Song SH, Kim IJ, et al. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients. Diabetes Res Clin Pract 2012;97:251-7
    • (2012) Diabetes Res Clin Pract , vol.97 , pp. 251-257
    • Kim, S.S.1    Song, S.H.2    Kim, I.J.3
  • 9
    • 79956209682 scopus 로고    scopus 로고
    • Glomerular and tubular damage markers are elevated in patients with diabetes
    • Nauta FL, Boertien WE, Bakker SJ, et al. Glomerular and tubular damage markers are elevated in patients with diabetes. Diabetes Care 2011;34:975-81
    • (2011) Diabetes Care , vol.34 , pp. 975-981
    • Nauta, F.L.1    Boertien, W.E.2    Bakker, S.J.3
  • 10
    • 77956855578 scopus 로고    scopus 로고
    • Neutrophil gelatinaseassociated lipocalin (NGAL) and kidney injury molecule 1 (KIM1) in patients with diabetic nephropathy: A cross-sectional study and the effects of lisinopril
    • Nielsen SE, Schjoedt KJ, Astrup AS, et al. Neutrophil gelatinaseassociated lipocalin (NGAL) and kidney injury molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril. Diabet Med 2010;27:1144-50
    • (2010) Diabet Med , vol.27 , pp. 1144-1150
    • Nielsen, S.E.1    Schjoedt, K.J.2    Astrup, A.S.3
  • 12
    • 79954503423 scopus 로고    scopus 로고
    • Albuminuria, proteinuria, and novel urine biomarkers as predictors of long-term allograft outcomes in kidney transplant recipients
    • Nauta FL, Bakker SJ, van Oeveren W, et al. Albuminuria, proteinuria, and novel urine biomarkers as predictors of long-term allograft outcomes in kidney transplant recipients. Am J Kidney Dis 2011;57:733-43
    • (2011) Am J Kidney Dis , vol.57 , pp. 733-743
    • Nauta, F.L.1    Bakker, S.J.2    Van Oeveren, W.3
  • 13
    • 84953329409 scopus 로고    scopus 로고
    • Efficacy of urinary N-acetyl-b-D-glucosaminidase to evaluate early renal tubular damage as a consequence of type 2 diabetes mellitus: A cross-sectional study
    • Patel DN, Kalia K. Efficacy of urinary N-acetyl-b-D-glucosaminidase to evaluate early renal tubular damage as a consequence of type 2 diabetes mellitus: a cross-sectional study. Int J Diabetes Developing Countries 2015;35:449-57
    • (2015) J Diabetes Developing Countries , vol.35 , pp. 449-457
    • Patel, D.N.1    Kalia, K.2
  • 14
    • 0026044922 scopus 로고
    • Contribution of hyperglycemia and renal damage to urinary C-peptide clearance in non-insulindependent diabetic patients
    • Aoki Y, Yanagisawa Y, Oguchi H, et al. Contribution of hyperglycemia and renal damage to urinary C-peptide clearance in non-insulindependent diabetic patients. Diabetes Res Clin Pract 1991;14:85-9
    • (1991) Diabetes Res Clin Pract , vol.14 , pp. 85-89
    • Aoki, Y.1    Yanagisawa, Y.2    Oguchi, H.3
  • 15
    • 84927768450 scopus 로고    scopus 로고
    • Urinary biomarker N-acetyl-beta-D-glucosaminidase can predict severity of renal damage in diabetic nephropathy
    • Sheira G, Noreldin N, Tamer A, et al. Urinary biomarker N-acetyl-beta-D-glucosaminidase can predict severity of renal damage in diabetic nephropathy. J Diabetes Metab Disord 2015;14:4
    • (2015) J Diabetes Metab Disord , vol.14 , pp. 4
    • Sheira, G.1    Noreldin, N.2    Tamer, A.3
  • 16
    • 0021813187 scopus 로고
    • Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
    • Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28: 412-9
    • (1985) Diabetologia , vol.28 , pp. 412-419
    • Matthews, D.R.1    Hosker, J.P.2    Rudenski, A.S.3
  • 17
    • 84908575350 scopus 로고    scopus 로고
    • Postprandial C-peptide to glucose ratio as a predictor of beta-cell function and its usefulness for staged management of type 2 diabetes
    • Lee EY, Hwang S, Lee SH, et al. Postprandial C-peptide to glucose ratio as a predictor of beta-cell function and its usefulness for staged management of type 2 diabetes. J Diabetes Invest 2014;5:517-24
    • (2014) J Diabetes Invest , vol.5 , pp. 517-524
    • Lee, E.Y.1    Hwang, S.2    Lee, S.H.3
  • 18
    • 78449313052 scopus 로고    scopus 로고
    • Ethnic coefficients for glomerular filtration rate estimation by the Modification of Diet in Renal Disease study equations in the Korean population
    • Lee CS, Cha RH, Lim YH, et al. Ethnic coefficients for glomerular filtration rate estimation by the Modification of Diet in Renal Disease study equations in the Korean population. J Korean Med Sci 2010;25:1616-25
    • (2010) J Korean Med Sci , vol.25 , pp. 1616-1625
    • Lee, C.S.1    Cha, R.H.2    Lim, Y.H.3
  • 19
    • 84897814629 scopus 로고    scopus 로고
    • Comparison of two creatinine-based equations for predicting decline in renal function in type 2 diabetic patients with nephropathy in a Korean population
    • Lee EY, Lee YM, Choi KH, et al. Comparison of two creatinine-based equations for predicting decline in renal function in type 2 diabetic patients with nephropathy in a Korean population. Int J Endocrinol 2013;2013:848963
    • (2013) J Endocrinol , vol.2013 , pp. 848963
    • Lee, E.Y.1    Lee, Y.M.2    Choi, K.H.3
  • 20
    • 0026280088 scopus 로고
    • Results of amulticenter study of provisional reference ranges for beta-N-acetylglucosaminidase in urine of adults
    • Klein G. Results of amulticenter study of provisional reference ranges for beta-N-acetylglucosaminidase in urine of adults. Wien Klin Wochenschr 1991;103:50-1
    • (1991) Wien Klin Wochenschr , vol.103 , pp. 50-51
    • Klein, G.1
  • 21
    • 84907698945 scopus 로고    scopus 로고
    • KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease
    • Eknoyan G, Lameire N, Eckardt K, et al. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 2013;3:5-14
    • (2013) Kidney Int , vol.3 , pp. 5-14
    • Eknoyan, G.1    Lameire, N.2    Eckardt, K.3
  • 22
    • 0036842174 scopus 로고    scopus 로고
    • Urinary N-acetyl-b-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis
    • Bazzi C, Petrini C, Rizza V, et al. Urinary N-acetyl-b-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Nephrol Dial Transplant 2002;17:1890-6
    • (2002) Nephrol Dial Transplant , vol.17 , pp. 1890-1896
    • Bazzi, C.1    Petrini, C.2    Rizza, V.3
  • 23
    • 68049144273 scopus 로고    scopus 로고
    • Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery
    • Han WK, Wagener G, Zhu Y, et al. Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery. Clin J Am Soc Nephrol 2009;4:873-82
    • (2009) Clin J Am Soc Nephrol , vol.4 , pp. 873-882
    • Han, W.K.1    Wagener, G.2    Zhu, Y.3
  • 24
    • 0027410225 scopus 로고
    • Enzymuria in non-insulin-dependent diabetic patients: Signs of tubular cell dysfunction
    • Ikenaga H, Suzuki H, Ishii N, et al. Enzymuria in non-insulin-dependent diabetic patients: signs of tubular cell dysfunction. Clin Sci (Lond) 1993;84:469-75
    • (1993) Clin Sci (Lond) , vol.84 , pp. 469-475
    • Ikenaga, H.1    Suzuki, H.2    Ishii, N.3
  • 25
    • 0024639543 scopus 로고
    • Tubular dysfunction in the early stage of diabetic nephropathy
    • Tanaka A, Shima K, Fukuda M, et al. Tubular dysfunction in the early stage of diabetic nephropathy. Med J Osaka Univ 1989;38:57-63
    • (1989) Med J Osaka Univ , vol.38 , pp. 57-63
    • Tanaka, A.1    Shima, K.2    Fukuda, M.3
  • 26
    • 33750736645 scopus 로고    scopus 로고
    • How does proteinuria cause progressive renal damage?
    • Abbate M, Zoja C, Remuzzi G. How does proteinuria cause progressive renal damage? J Am Soc Nephrol 2006;17:2974-84
    • (2006) J Am Soc Nephrol , vol.17 , pp. 2974-2984
    • Abbate, M.1    Zoja, C.2    Remuzzi, G.3
  • 27
    • 0031916819 scopus 로고    scopus 로고
    • Proximal tubular basement membrane width in insulin-dependent diabetes mellitus
    • Brito PL, Fioretto P, Drummond K, et al. Proximal tubular basement membrane width in insulin-dependent diabetes mellitus. Kidney Int 1998;53:754-61
    • (1998) Kidney Int , vol.53 , pp. 754-761
    • Brito, P.L.1    Fioretto, P.2    Drummond, K.3
  • 28
    • 85011536682 scopus 로고    scopus 로고
    • Prognostic value of tubulointerstitial lesions, urinary N-acetyl-beta-D-glucosaminidase, and urinary beta2-microglobulin in patients with type 2 diabetes and biopsy-proven diabetic nephropathy
    • Mise K, Hoshino J, Ueno T, et al. Prognostic value of tubulointerstitial lesions, urinary N-acetyl-beta-D-glucosaminidase, and urinary beta2-microglobulin in patients with type 2 diabetes and biopsy-proven diabetic nephropathy. Clin J Am Soc Nephrol 2016;11:593-601
    • (2016) Clin J Am Soc Nephrol , vol.11 , pp. 593-601
    • Mise, K.1    Hoshino, J.2    Ueno, T.3
  • 29
    • 0023229647 scopus 로고
    • Contribution of glycemic control to the levels of urinary N-acetyl-beta-D-glucosaminidase (NAG), total protein, beta 2-microglobulin and serum NAG in type 1 (insulindependent) diabetes mellitus without macroalbuminuria
    • Watanabe Y, Nunoi K, Maki Y, et al. Contribution of glycemic control to the levels of urinary N-acetyl-beta-D-glucosaminidase (NAG), total protein, beta 2-microglobulin and serum NAG in type 1 (insulindependent) diabetes mellitus without macroalbuminuria. Clin Nephrol 1987;28:227-31
    • (1987) Clin Nephrol , vol.28 , pp. 227-231
    • Watanabe, Y.1    Nunoi, K.2    Maki, Y.3
  • 30
    • 0031944358 scopus 로고    scopus 로고
    • Relationship between serum 1,5-anhydroglucitol and urinary excretion of N-acetylglucosaminidase and albumin determined at onset of NIDDM with 3-year follow-up
    • Yamanouchi T, Kawasaki T, Yoshimura T, et al. Relationship between serum 1,5-anhydroglucitol and urinary excretion of N-acetylglucosaminidase and albumin determined at onset of NIDDM with 3-year follow-up. Diabetes Care 1998;21:619-24
    • (1998) Diabetes Care , vol.21 , pp. 619-624
    • Yamanouchi, T.1    Kawasaki, T.2    Yoshimura, T.3
  • 31
    • 84864615705 scopus 로고    scopus 로고
    • Ipragliflozin (ASP1941), a selective sodium-dependent glucose cotransporter 2 inhibitor, safely stimulates urinary glucose excretion without inducing hypoglycemia in healthy Japanese subjects
    • Kadokura T, Saito M, Utsuno A, et al. Ipragliflozin (ASP1941), a selective sodium-dependent glucose cotransporter 2 inhibitor, safely stimulates urinary glucose excretion without inducing hypoglycemia in healthy Japanese subjects. Diabetol Int 2011;2:172-82
    • (2011) Diabetol Int , vol.2 , pp. 172-182
    • Kadokura, T.1    Saito, M.2    Utsuno, A.3
  • 32
    • 77951524737 scopus 로고    scopus 로고
    • Early urinary markers of diabetic kidney disease: A nested case-control study from the Diabetes Control and Complications Trial (DCCT)
    • Kern EF, Erhard P, Sun W, et al. Early urinary markers of diabetic kidney disease: a nested case-control study from the Diabetes Control and Complications Trial (DCCT). Am J Kidney Dis 2010;55: 824-34
    • (2010) Am J Kidney Dis , vol.55 , pp. 824-834
    • Kern, E.F.1    Erhard, P.2    Sun, W.3
  • 33
    • 79960253676 scopus 로고    scopus 로고
    • Glycated albumin is a useful glycation index for monitoring fluctuating and poorly controlled type 2 diabetic patients
    • Lee EY, Lee BW, Kim D, et al. Glycated albumin is a useful glycation index for monitoring fluctuating and poorly controlled type 2 diabetic patients. Acta Diabetol 2011;48:167-72
    • (2011) Acta Diabetol , vol.48 , pp. 167-172
    • Lee, E.Y.1    Lee, B.W.2    Kim, D.3
  • 34
    • 84867263826 scopus 로고    scopus 로고
    • The ratio of glycated albumin to glycated haemoglobin correlates with insulin secretory function
    • Kim D, Kim KJ, Huh JH, et al. The ratio of glycated albumin to glycated haemoglobin correlates with insulin secretory function. Clin Endocrinol 2012;77:679-83
    • (2012) Clin Endocrinol , vol.77 , pp. 679-683
    • Kim, D.1    Kim, K.J.2    Huh, J.H.3
  • 35
    • 84869501689 scopus 로고    scopus 로고
    • Serum glycated albumin predicts the progression of carotid arterial atherosclerosis
    • Song SO, Kim KJ, Lee BW, et al. Serum glycated albumin predicts the progression of carotid arterial atherosclerosis. Atherosclerosis 2012;225: 450-5
    • (2012) Atherosclerosis , vol.225 , pp. 450-455
    • Song, S.O.1    Kim, K.J.2    Lee, B.W.3
  • 36
    • 84939810275 scopus 로고    scopus 로고
    • Glycemic variability: How do we measure it and why is it important?
    • Suh S, Kim JH. Glycemic variability: how do we measure it and why is it important? Diabetes Metab J 2015;39:273-82
    • (2015) Diabetes Metab J , vol.39 , pp. 273-282
    • Suh, S.1    Kim, J.H.2
  • 37
    • 0023118080 scopus 로고
    • Comparison of N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase activities for evaluation of microangiopathy in diabetes mellitus
    • Shimojo N, Kitahashi S, Naka K, et al. Comparison of N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase activities for evaluation of microangiopathy in diabetes mellitus. Metabolism 1987;36: 277-80
    • (1987) Metabolism , vol.36 , pp. 277-280
    • Shimojo, N.1    Kitahashi, S.2    Naka, K.3
  • 38
    • 84889093597 scopus 로고    scopus 로고
    • Urinary n-acetyl-beta-Dglucosaminidase excretion: An indicator of neuropathy in type 2 diabetes
    • Kopf S, Oikonomou D, Zdunek D, et al. Urinary n-acetyl-beta-Dglucosaminidase excretion: an indicator of neuropathy in type 2 diabetes. Exp Clin Endocrinol Diabetes 2013;121:601-6
    • (2013) Exp Clin Endocrinol Diabetes , vol.121 , pp. 601-606
    • Kopf, S.1    Oikonomou, D.2    Zdunek, D.3
  • 39
    • 0032710793 scopus 로고    scopus 로고
    • Prospective evaluation of urinary N-acetyl-beta-D-glucosaminidase with respect to macrovascular disease in elderly type 2 diabetic patients
    • Weitgasser R, Schnoell F, Gappmayer B, et al. Prospective evaluation of urinary N-acetyl-beta-D-glucosaminidase with respect to macrovascular disease in elderly type 2 diabetic patients. Diabetes Care 1999;22: 1882-6
    • (1999) Diabetes Care , vol.22 , pp. 1882-1886
    • Weitgasser, R.1    Schnoell, F.2    Gappmayer, B.3
  • 40
    • 84928344188 scopus 로고    scopus 로고
    • The insulin resistance but not the insulin secretion parameters have changed in the Korean population during the last decade
    • Yang HK, Lee JH, Choi IY, et al. The insulin resistance but not the insulin secretion parameters have changed in the Korean population during the last decade. Diabetes Metab J 2015;39:117-25
    • (2015) Diabetes Metab J , vol.39 , pp. 117-125
    • Yang, H.K.1    Lee, J.H.2    Choi, I.Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.